20.03.2012 07:05 Uhr, Quelle: Wallstreet online

Kuros and Synthes, Inc. Announce License and Development Agreement

ZÜRICH, Switzerland and WEST CHESTER, Pennsylvania, March 20, 2012 /PRNewswire/ First Partnering Deal Based on Kuros´ Synthetic Matrix Technologies Kuros Biosurgery AG, a biotechnology company focused on the development of novel …

Weiterlesen bei Wallstreet online